Thyrotoxic Periodic Paralysis and Polymorphisms of the ADRB2, AR, and GABRA3 Genes in Men with Graves Disease
Suyeon Park (Park S), Tae Yong Kim (Kim TY), Soyoung Sim (Sim S), Seonhee Lim (Lim S), Mijin Kim (Kim M), Hyemi Kwon (Kwon H), Min Ji Jeon (Jeon MJ), Won Gu Kim (Kim WG), Young Kee Shong (Shong YK), Won Bae Kim (Kim WB)
Endocrinol Metab. 2016;31(1):142-146.   Published online 2016 Mar 16     DOI: https://doi.org/10.3803/EnM.2016.31.1.142
Citations to this article as recorded by Crossref logo
RNASET2 ,GPR174 , and PTPN22 gene polymorphisms are related to the risk of liver damage associated with the hyperthyroidism in patients with Graves’ disease
Qing Zhang, Shaozheng Liu, Yanxing Guan, Qingjie Chen, Qing Zhang, Xiang Min
Journal of Clinical Laboratory Analysis.2018; 32(2): e22258.     CrossRef
Articles inEndocrinology and Metabolismin 2016
Won-Young Lee
Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
Periodic Paralysis and Encephalopathy as Initial Manifestations of Graves’ Disease
Theocharis Tsironis, Athanasios Tychalas, Dimitrios Kiourtidis, Jannis Kountouras, Georgia Xiromerisiou, Jobst Rudolf, Georgia Deretzi
The Neurologist.2017; 22(4): 134.     CrossRef
Thyrotoxic periodic paralysis
Zdeněk Doležel, Dana Novotná, Helena Schneiderová, Jan Papež, Martin Jouza
Pediatrie pro praxi.2016; 17(6): 379.     CrossRef